Potentially company changing news.
This is seriously impressive data. 5 from 5.
Avg 27 mnths with ZERO further morbidity or mortality with a disease where many women would have disease progression within 24 mnths.
I'm not sure why there hasnt been a similar SP spike as we saw with BD1 & Bit. I'm reading this news trying to pick holes in it yet i cant find anything significant.
Suffice to say the longer the participants in this study live without disease progression the more credible PTX-200 becomes.
PTX Price at posting:
8.7¢ Sentiment: Buy Disclosure: Held
